Treatment of mineralocorticoid-resistant renal hyperkalemia with hypertension (type II pseudohypoaldosteronism).

Abstract

A 16 year old girl with the rare syndrome characterised by hypertension, hyperkalemia, and acidosis was treated with a range of drugs, including thiazides, frusemide, and beta-adrenoceptor antagonists. None of the agents normalised the hypertension and biochemical abnormalities. Best results were obtained with methyclothiazide in full dosage, which… (More)

Topics

Cite this paper

@article{Wayne1986TreatmentOM, title={Treatment of mineralocorticoid-resistant renal hyperkalemia with hypertension (type II pseudohypoaldosteronism).}, author={Victor S Wayne and Jim R. Stockigt and Garry L R Jennings}, journal={Australian and New Zealand journal of medicine}, year={1986}, volume={16 2}, pages={221-3} }